Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

BACKGROUND: Thanks to the advances in genomics and targeted treatments, more and more prediction models based on biomarkers are being developed to predict potential benefit from treatments in a randomized clinical trial. Despite the methodological framework for the development and validation of pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Ternès, Nils, Rotolo, Federico, Michiels, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441049/
https://www.ncbi.nlm.nih.gov/pubmed/28532387
http://dx.doi.org/10.1186/s12874-017-0354-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441049/
https://www.ncbi.nlm.nih.gov/pubmed/28532387
http://dx.doi.org/10.1186/s12874-017-0354-0

Ejemplares similares